Relenza Powder
Product Images NDC 0173-0681

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Relenza (NDC 0173-0681). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zanamivir Structural Formula (Relenza Spl Graphic 01)

FDA Label Image

Relenza Logo (Relenza Spl Graphic 02)

This text is a description of how to use the DISKHALER device to inhale medication. It includes information on keeping the device clean, the purpose of the mouthpiece, how to advance to the next dose, how to release the medication, and the components of the device.*

FDA Label Image

Parts Of The Diskhaler (Relenza Spl Graphic 03)

FDA Label Image

Step A: Load The Medicine In Diskhaler (Relenza Spl Graphic 04)

FDA Label Image

Step B: Steps 1, 2, 3, And 4 (Relenza Spl Graphic 05)

FDA Label Image

Step C: Steps 1 And 2 (Relenza Spl Graphic 06)

FDA Label Image

Step D: Steps 1 And 2 (Relenza Spl Graphic 07)

FDA Label Image

Relenza Carton (Relenza Spl Graphic 08)

FDA Label Image

Relenza Spl Graphic 09

FDA Label Image

Relenza Spl Graphic 10

FDA Label Image

Relenza Spl Graphic 11

FDA Label Image

Relenza Spl Graphic 12

FDA Label Image

Relenza Spl Graphic 13

FDA Label Image

Relenza Spl Graphic 14

FDA Label Image

Relenza Spl Graphic 15

This is a description of a medication called RELENZA, with NDC code 0173-0681-01, which is an inhalation powder containing 20mg of zanamivir. Each blister contains 5mg of zanamivir along with lactose. The medication should be used with the DISKHALER inhalation device only, and there are patient information and instructions enclosed for its use. The medication must be stored at a temperature between 15° to 30°C (59° to 86°F). It contains 5 RELANZA ROTADISKS, each with 4 blisters containing 5mg zanamivir, and one DISKHALER inhalation device. The dosage information should be obtained from the prescribing information. This medication is intended for oral inhalation only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.